Press Release Archive

All Press Releases

08.26.2004
Forest Laboratories Submits Response for Lexapro(R) for Panic Disorder
07.29.2004
FDA Approves Campral(R) (Acamprosate Calcium) Delayed-Release Tablets for the Treatment of Alcohol Dependence
07.20.2004
Forest Laboratories Reports Fiscal First Quarter Earnings of $.60 Per Share
07.20.2004
Forest Laboratories, Inc. Announces Share Repurchase Program
07.13.2004
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 First Quarter Earnings
07.06.2004
Forest Laboratories, Inc. and PAION GmbH Announce Development and Marketing Agreement for Desmoteplase - Novel Investigational Treatment for Acute Stroke
06.29.2004
Forest Announces Request for Information From New York State Office of the Attorney General
06.24.2004
Forest Announces Results of Recently Completed Lexapro(R) Pediatric Depression Clinical Trial
06.24.2004
Forest Discusses Disclosure of Citalopram Clinical Trial Data in Children and Adolescents
05.06.2004
Depressed Patients Showed Improvement with Lexapro(TM) After Failure with Initial SSRI Treatment